We investigate the immunological mechanisms underlying primary immunodeficiencies, with the aim of improving diagnostic precision, patient stratification, and treatment. By integrating clinical data with molecular and genetic profiling, we seek to better understand disease heterogeneity and identify biomarkers that inform prognosis and therapeutic decision-making. Our work focuses on translating these insights into clinically actionable diagnostics and personalized management strategies for patients with inborn errors of immunity.